295 related articles for article (PubMed ID: 14762061)
1. A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 21q.
Yamada Y; Watanabe H; Miura F; Soejima H; Uchiyama M; Iwasaka T; Mukai T; Sakaki Y; Ito T
Genome Res; 2004 Feb; 14(2):247-66. PubMed ID: 14762061
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 11q: comparison with chromosome 21q.
Yamada Y; Shirakawa T; Taylor TD; Okamura K; Soejima H; Uchiyama M; Iwasaka T; Mukai T; Muramoto K; Sakaki Y; Ito T
DNA Seq; 2006 Aug; 17(4):300-6. PubMed ID: 17312950
[TBL] [Abstract][Full Text] [Related]
3. Isolation and enrichment of human genomic CpG islands by methylation-sensitive mirror orientation selection.
Huang Q; Baum L; Huang JF; You JP; Wang F; Wang J; Zheng J; Yan XC; Xia H; Zhao YH; Kuang H; Fu WL
Anal Biochem; 2007 Jun; 365(2):153-64. PubMed ID: 17481566
[TBL] [Abstract][Full Text] [Related]
4. Massive parallel bisulfite sequencing of CG-rich DNA fragments reveals that methylation of many X-chromosomal CpG islands in female blood DNA is incomplete.
Zeschnigk M; Martin M; Betzl G; Kalbe A; Sirsch C; Buiting K; Gross S; Fritzilas E; Frey B; Rahmann S; Horsthemke B
Hum Mol Genet; 2009 Apr; 18(8):1439-48. PubMed ID: 19223391
[TBL] [Abstract][Full Text] [Related]
5. Allelic methylation status of CpG islands on chromosome 21q in patients with Trisomy 21.
Xia YY; Ding YB; Liu XQ; Chen XM; Cheng SQ; Li LB; Ma MF; He JL; Wang YX
Mol Med Rep; 2014 May; 9(5):1681-8. PubMed ID: 24573226
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the methylation status around parent-of-origin detectable SNPs in imprinted genes.
Nakayashiki N; Takamiya M; Shimamoto K; Aoki Y; Hashiyada M
Forensic Sci Int Genet; 2009 Sep; 3(4):227-32. PubMed ID: 19647707
[TBL] [Abstract][Full Text] [Related]
7. Identification of 27 5' CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers.
Hagihara A; Miyamoto K; Furuta J; Hiraoka N; Wakazono K; Seki S; Fukushima S; Tsao MS; Sugimura T; Ushijima T
Oncogene; 2004 Nov; 23(53):8705-10. PubMed ID: 15467763
[TBL] [Abstract][Full Text] [Related]
8. Identification of PRTFDC1 silencing and aberrant promoter methylation of GPR150, ITGA8 and HOXD11 in ovarian cancers.
Cai LY; Abe M; Izumi S; Imura M; Yasugi T; Ushijima T
Life Sci; 2007 Mar; 80(16):1458-65. PubMed ID: 17303177
[TBL] [Abstract][Full Text] [Related]
9. Identification of differentially methylated sites within unmethylated DNA domains in normal and cancer cells.
Tryndyak V; Kovalchuk O; Pogribny IP
Anal Biochem; 2006 Sep; 356(2):202-7. PubMed ID: 16824473
[TBL] [Abstract][Full Text] [Related]
10. Detailed methylation analysis of CpG islands on human chromosome region 9p21.
Weeks RJ; Morison IM
Genes Chromosomes Cancer; 2006 Apr; 45(4):357-64. PubMed ID: 16372313
[TBL] [Abstract][Full Text] [Related]
11. Features and trend of loss of promoter-associated CpG islands in the human and mouse genomes.
Jiang C; Han L; Su B; Li WH; Zhao Z
Mol Biol Evol; 2007 Sep; 24(9):1991-2000. PubMed ID: 17591602
[TBL] [Abstract][Full Text] [Related]
12. The CpG island in intron 22 of the factor VIII gene is predominantly methylated on the X chromosome of human males.
De Brasi CD; Bowen DJ; Collins PW; Larripa IB
J Hum Genet; 2002; 47(5):239-42. PubMed ID: 12032591
[TBL] [Abstract][Full Text] [Related]
13. A PCR-based method for studying DNA methylation.
Ariel M
Methods Mol Biol; 2001; 181():205-16. PubMed ID: 12843452
[TBL] [Abstract][Full Text] [Related]
14. Predicting methylation status of CpG islands in the human brain.
Fang F; Fan S; Zhang X; Zhang MQ
Bioinformatics; 2006 Sep; 22(18):2204-9. PubMed ID: 16837523
[TBL] [Abstract][Full Text] [Related]
15. Monoallelic expression of human PEG1/MEST is paralleled by parent-specific methylation in fetuses.
Riesewijk AM; Hu L; Schulz U; Tariverdian G; Höglund P; Kere J; Ropers HH; Kalscheuer VM
Genomics; 1997 Jun; 42(2):236-44. PubMed ID: 9192843
[TBL] [Abstract][Full Text] [Related]
16. Fidelity of the methylation pattern and its variation in the genome.
Ushijima T; Watanabe N; Okochi E; Kaneda A; Sugimura T; Miyamoto K
Genome Res; 2003 May; 13(5):868-74. PubMed ID: 12727906
[TBL] [Abstract][Full Text] [Related]
17. Gene body-specific methylation on the active X chromosome.
Hellman A; Chess A
Science; 2007 Feb; 315(5815):1141-3. PubMed ID: 17322062
[TBL] [Abstract][Full Text] [Related]
18. Microarray-based DNA methylation profiling: technology and applications.
Schumacher A; Kapranov P; Kaminsky Z; Flanagan J; Assadzadeh A; Yau P; Virtanen C; Winegarden N; Cheng J; Gingeras T; Petronis A
Nucleic Acids Res; 2006; 34(2):528-42. PubMed ID: 16428248
[TBL] [Abstract][Full Text] [Related]
19. Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas.
Furuta J; Nobeyama Y; Umebayashi Y; Otsuka F; Kikuchi K; Ushijima T
Cancer Res; 2006 Jun; 66(12):6080-6. PubMed ID: 16778180
[TBL] [Abstract][Full Text] [Related]
20. CpG islands--'a rough guide'.
Illingworth RS; Bird AP
FEBS Lett; 2009 Jun; 583(11):1713-20. PubMed ID: 19376112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
